Russo Diana, Mariani Pierluigi, Caponio Vito Carlo Alberto, Lo Russo Lucio, Fiorillo Luca, Zhurakivska Khrystyna, Lo Muzio Lorenzo, Laino Luigi, Troiano Giuseppe
Multidisciplinary Department of Medical-Surgical and Dental Specialties, University of Campania "Luigi Vanvitelli", 80122 Napoli, Italy.
Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
Cancers (Basel). 2021 Nov 17;13(22):5755. doi: 10.3390/cancers13225755.
(1) Background: An accurate prediction of cancer survival is very important for counseling, treatment planning, follow-up, and postoperative risk assessment in patients with Oral Squamous Cell Carcinoma (OSCC). There has been an increased interest in the development of clinical prognostic models and nomograms which are their graphic representation. The study aimed to revise the prognostic performance of clinical-pathological prognostic models with internal validation for OSCC. (2) Methods: This systematic review was performed according to the chapter on searching, the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines, and the Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies (CHARMS). (3) Results: Six studies evaluating overall survival in patients with OSCC were identified. All studies performed internal validation, while only four models were externally validated. (4) Conclusions: Based on the results of this systematic review, it is possible to state that it is necessary to carry out internal validation and shrinkage to correct overfitting and provide an adequate performance for optimism. Moreover, calibration, discrimination and nonlinearity of continuous predictors should always be examined. To reduce the risk of bias the study design used should be prospective and imputation techniques should always be applied to handle missing data. In addition, the complete equation of the prognostic model must be reported to allow updating, external validation in a new context and the subsequent evaluation of the impact on health outcomes and on the cost-effectiveness of care.
(1) 背景:准确预测癌症生存率对于口腔鳞状细胞癌(OSCC)患者的咨询、治疗规划、随访及术后风险评估非常重要。临床预后模型及其图形表示形式列线图的开发越来越受到关注。本研究旨在通过内部验证来修正OSCC临床病理预后模型的预后性能。(2) 方法:本系统评价按照检索章节、PRISMA(系统评价和Meta分析的首选报告项目)指南以及预测模型研究系统评价的关键评估和数据提取(CHARMS)进行。(3) 结果:确定了6项评估OSCC患者总生存期的研究。所有研究均进行了内部验证,而只有4个模型进行了外部验证。(4) 结论:基于本系统评价的结果,可以指出有必要进行内部验证和收缩以校正过度拟合并为乐观估计提供足够的性能。此外,应始终检查连续预测因子的校准、区分度和非线性。为降低偏倚风险,所采用的研究设计应是前瞻性的,并且应始终应用插补技术来处理缺失数据。此外,必须报告预后模型的完整方程,以便进行更新、在新背景下进行外部验证以及随后评估对健康结局和护理成本效益的影响。